Literature DB >> 31981477

SFPQ Is an FTO-Binding Protein that Facilitates the Demethylation Substrate Preference.

Haiping Song1, Ye Wang1, Ruixiang Wang2, Xiao Zhang1, Yaping Liu1, Guifang Jia3, Peng R Chen4.   

Abstract

The fat mass and obesity-associated protein (FTO) is the first identified demethylase of the internal RNA modification N6-methyladenosine (m6A), which also exhibits demethylation activity toward N6,2'-O-dimethyladenosine (m6Am) and N1-methyladenosine (m1A). Demethylation of m6A at specific sites on target transcripts is a key enzymatic function of FTO that modulates diverse physiological and/or pathological processes. However, how FTO selects target RNA and whether additional interaction proteins facilitate this process remain elusive. Herein, via the genetically encoded and site-specific photocrosslinking strategy, we identified the major RNA-binding protein SFPQ as a direct interaction partner of FTO. Our study showed that FTO and SFPQ were located in close proximity throughout the transcriptome and that overexpression of SFPQ led to the demethylation of adjacent m6As, likely through recruiting FTO to these specific RNA sites. These results uncovered a new layer of regulation mechanism that may assist FTO to gain substrate specificity.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DiZPK; FTO; SFPQ; crosslinking MS analysis program; m(6)A demethylation; site-specific photocrosslinking strategy; substrate selection

Mesh:

Substances:

Year:  2020        PMID: 31981477     DOI: 10.1016/j.chembiol.2020.01.002

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  8 in total

Review 1.  Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases.

Authors:  Anil K Chokkalla; Suresh L Mehta; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-23       Impact factor: 6.200

Review 2.  Progress and application of epitranscriptomic m6A modification in gastric cancer.

Authors:  Yitian Xu; Chen Huang
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

Review 3.  Role of m6A Methylation in the Occurrence and Development of Heart Failure.

Authors:  Shaowei Fan; Yuanhui Hu
Journal:  Front Cardiovasc Med       Date:  2022-06-24

4.  Effect of Posttranslational Modifications on the Structure and Activity of FTO Demethylase.

Authors:  Michał Marcinkowski; Tomaš Pilžys; Damian Garbicz; Jan Piwowarski; Damian Mielecki; Grzegorz Nowaczyk; Michał Taube; Maciej Gielnik; Maciej Kozak; Maria Winiewska-Szajewska; Ewa Szołajska; Janusz Dębski; Agnieszka M Maciejewska; Kaja Przygońska; Karolina Ferenc; Elżbieta Grzesiuk; Jarosław Poznański
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

5.  The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.

Authors:  Wenfa Yi; Yong Yu; Yafei Li; Juan Yang; Shuying Gao; Lingfen Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding.

Authors:  Wei Wang; Fei Shao; Xueying Yang; Juhong Wang; Rongxuan Zhu; Yannan Yang; Gaoxiang Zhao; Dong Guo; Yingli Sun; Jie Wang; Qi Xue; Shugeng Gao; Yibo Gao; Jie He; Zhimin Lu
Journal:  Nat Commun       Date:  2021-06-21       Impact factor: 14.919

7.  Multilateral Bioinformatics Analyses Reveal the Function-Oriented Target Specificities and Recognition of the RNA-Binding Protein SFPQ.

Authors:  Kei Iida; Masatoshi Hagiwara; Akihide Takeuchi
Journal:  iScience       Date:  2020-06-28

8.  The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.

Authors:  Sébastien Relier; Eric Rivals; Alexandre David
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.